Measurement of local cerebral glucose metabolism (lCMRGlc) by positron emission
tomography (PET) and 18 F-2-fluoro-2-deoxy-d-glucose (FDG) has become a standard …

The purpose of this study was to compare the diagnostic accuracy of glucose metabolism
and amyloid deposition as demonstrated by 18F-FDG and Pittsburg Compound B (PiB) PET …

BACKGROUND: The diagnosis of dementia, along with the prediction of who will develop
dementia, has been assisted by the development of the brain imaging techniques of …

Background: Few studies have compared the accuracy of [18F] fluorodeoxyglucose (FDG)
PET to the accuracy of clinical and pathologic diagnosis in dementia patients. Methods …

The purpose of this article is to present a selective and concise summary of
fluorodeoxyglucose (FDG) positron emission tomography (PET) in dementia imaging. FDG …

Brain imaging with glucose (18F-FDG) PET or blood flow (hexamethylpropyleneamine
oxime) SPECT is widely used for the differential diagnosis of dementia, though direct …

Purpose We report the first clinicopathological series of longitudinal FDG-PET scans in post-
mortem (PM) verified cognitively normal elderly (NL) followed to the onset of Alzheimer's …

FDG-PET ([18F] fluorodeoxyglucose positron emission tomography) is frequently used to
improve the differential diagnosis of dementia. However, a fundamental methodological …

Dementing illnesses such as Alzheimer's disease (AD) progressively devastate human brain
tissue and consequently the health and lives of people afflicted by these disorders. One of …

The clinical identification and differential diagnosis of dementias is especially challenging in
the early stages, but the need for early, accurate diagnosis has become more important, now …